Telomir Pharmaceuticals, INC. 8-K Filing
Ticker: TELO · Form: 8-K · Filed: Dec 17, 2025 · CIK: 1971532
Sentiment: neutral
Filing Stats: 647 words · 3 min read · ~2 pages · Grade level 16.7 · Accepted 2025-12-17 16:01:45
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-25-028126.txt ( ) — 206KB
- telo-20251217.xsd (EX-101.SCH) — 3KB
- telo-20251217_lab.xml (EX-101.LAB) — 34KB
- telo-20251217_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TELOMIR PHARMACEUTICALS, INC. Dated: December 17, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer